Multiple sclerosis and COVID‐19: The Swedish experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple sclerosis and COVID‐19: The Swedish experience

Published:2021-05-24 Issue:3 Volume:144 Page:229-235
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Landtblom Anne‐Marie¹²,Berntsson Shala G.¹^ORCID,Boström Inger²,Iacobaeus Ellen³^ORCID

Affiliation:

1. Department of Neuroscience Uppsala University Uppsala Sweden

2. Department of Biomedical and Clinical Sciences Linköping University Linköping Sweden

3. Department of Clinical Neuroscience Division of Neurology Karolinska Institute and Karolinska University Hospital Stockholm Sweden

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ane.13453

Reference58 articles.

1. Immunology of Multiple Sclerosis

2. Common comorbidities and survival in MS: Risk for stroke, type 1 diabetes and infections

3. Infections in patients with multiple sclerosis: A national cohort study in Sweden

4. Infections in patients diagnosed with multiple sclerosis: A multi-database study

5. Multiple Sclerosis and Risk of Infection-Related Hospitalization and Death in US Veterans

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose rituximab regimen does not increase severe COVID-19 risk in patients with neuroimmune diseases during the pandemic: a cross-sectional study;2024-07-29

2. Exploring the working life of people with multiple sclerosis during the COVID-19 pandemic in Sweden;BMC Public Health;2024-05-23

3. The possible causal relationship between COVID-19 and imaging markers of cerebral small vessel disease: a Mendelian randomization study;Neurological Research;2024-05-02

4. Improving telehealth for persons with multiple sclerosis – a cross-sectional study from the Australian MS longitudinal study;Disability and Rehabilitation;2023-12-13

5. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study;Journal of Clinical Medicine;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3